Status:
NOT_YET_RECRUITING
Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation
Lead Sponsor:
Texas Cardiac Arrhythmia Research Foundation
Conditions:
Atrial Fibrillation (AF)
Eligibility:
All Genders
18-85 years
Brief Summary
This study is designed to directly compare the safety and efficacy of PFA-based PVI+PWI vs PFA-based PVI+ VoM alcohol ablation in patients with Persistent AF.
Eligibility Criteria
Inclusion
- Symptomatic persistent AF; 1st or redo ablation with PVI-only in the earlier procedure
- Willing to provide informed consent
- Age: 18-85 years
Exclusion
- • Previous PWI or VoM ablation procedure
- Left ventricular ejection fraction \<40%
- Left atrial thrombus
- Myocardial infarction within last 60 days
- Cardiac surgery in the last 6 months
- Advanced renal failure
- Life expectancy \<1 year
- Pregnant women
- Unable or unwilling to provide informed consent
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT06878924
Start Date
May 1 2025
End Date
December 1 2027
Last Update
March 17 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.